Search

Search Constraints

You searched for: Author/Creator Fassan, M.

Search Results

1. A composite prognostic model for overall survival (OS) based on residual cancer burden (RCB) and tumor-infiltrating lymphocytes (TILs) on residual disease (RCB+TIL) in HER2+ breast cancer patients treated with neoadjuvant therapy: a multicenter study. (November 2022)

5. Concomitant IDH wild‐type glioblastoma and IDH1‐mutant anaplastic astrocytoma in a patient with constitutional mismatch repair deficiency syndrome. (20th February 2018)

6. Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis. Issue 7 (July 2016)

7. In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma. Issue 4 (1st June 2015)

8. In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma. Issue 4 (7th April 2014)